19:36:37 EDT Tue 23 Apr 2024
Enter Symbol
or Name
USA
CA



Shell Summary for July 4, 2018

2018-07-04 20:28 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange lost 1.82 points to 738.75 Wednesday. Melinda Rombouts's shell graduate and marijuana producer, Eve & Co. Inc. (EVE), began trading today. It reached an intraday high of 30 cents before closing at 29 cents on 195,000 shares. Eve owns a 220,000-square-foot greenhouse and 32 acres of adjacent land near London, Ont. It plans to increase the size of its greenhouse to one million square feet by March, 2019. To finance the expansion, it sold $10.8-million worth of shares at 25 cents. It also sold $10-million worth of debentures that are convertible into shares at 30 cents. Eve & Co. received its marijuana production licence in July, 2016, but it received its sales licence just last week, so there are no profit or loss figures yet to report. Eve's target customers are women.

Ms. Rombouts, 46, is Eve's president, its chief executive officer and a director. She studied plant biology. She co-founded Eve with her boyfriend, Dave Burch. Before growing marijuana, the couple grew algae (for customers such as fish feed and poultry feed makers) as well as flowers. Now that Eve is public, Ms. Rombouts gets a salary bump to $175,000 from $127,400. She holds 58 million shares or 27.5 per cent of Eve. Meanwhile, Mr. Burch holds 26.8 million shares or 12.7 per cent. He continues to work at Eve but is neither a director nor an officer.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed